A Phase I, Multiple Dose Study of PF-04447943 in Healthy Elderly Volunteers

Stopped early · Phase 1 · Has a placebo group

Conditions studied: Healthy, Elderly

In brief

To describe the safety, tolerability and pharmacokinetics of PF-04447943 after administration of multiple, ascending, oral doses to healthy elderly subjects.

Key facts

Study ID

NCT00736528

Run by

Pfizer

People needed

10

Starts

2008-08-01

Expected to finish

2008-09-01

Last updated by the study team

2009-02-25

Who can join

Age: 65 and older, up to 85. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy
• Elderly
• 65-85

You may not qualify if…

• Evidence or history of clinically significant unstable disease

Where it is running

• Pfizer Investigational Site — Gainesville, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.